Gilead Sciences, Inc. (BVMF:GILD34)

Gilead Sciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	810,786	711,991	489,800	569,244	507,475	379,262
Market Cap Growth	28.48%	45.36%	-13.96%	12.17%	33.81%	14.77%
Enterprise Value	886,845	813,844	566,369	662,706	618,792	391,108
Last Close Price	327.04	280.81	184.68	207.05	184.15	129.43
PE Ratio	18.76	239.83	17.82	23.45	14.63	593.74
PS Ratio	5.23	4.00	3.72	3.95	3.34	2.96
PB Ratio	7.09	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	16.60	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	15.74	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	5.76	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	11.71	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.73	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	18.16	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Capital (ROIC)	16.14%	14.07%	12.15%	14.38%	15.11%	13.94%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	5.33%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	6.02%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	1.93%	6.78%	7.88%	7.46%	8.59%	10.91%
Payout Ratio	49.10%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	0.90%	7.02%	8.20%	7.54%	8.67%	12.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.